Janus Henderson Group PLC Innoviva, Inc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 27,858 shares of INVA stock, worth $496,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,858

Previous 27,858 -0.0%

Holding current value

$496,986

Previous $456,000 17.76%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $4,737 - $5,395	-329 Reduced 1.17%	27,858 $456,000
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $43 - $50	3 Added 0.01%	28,187 $429,000
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $677 - $894	-55 Reduced 0.19%	28,184 $452,000
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $12 - $13	-1 Reduced -0.0%	28,239 $366,000
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $261 - $315	-23 Reduced 0.08%	28,240 $359,000
Q1 2023 May 15, 2023	SELL	$10.73 - $13.6 $705,368 - $894,036	-65,738 Reduced 69.93%	28,263 $317,000
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $79,709 - $93,083	-6,755 Reduced 6.7%	94,001 $1.25 Million
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $6,710 - $8,797	-578 Reduced 0.57%	100,756 $1.17 Million
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $257,946 - $358,098	18,013 Added 21.62%	101,334 $1.5 Million
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $349,845 - $460,323	-22,732 Reduced 21.43%	83,321 $1.61 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $149,967 - $176,454	9,426 Added 9.76%	106,053 $1.83 Million
Q3 2021 Nov 16, 2021	SELL	$13.06 - $17.24 $913,533 - $1.21 Million	-69,949 Reduced 41.99%	96,627 $1.62 Million
Q2 2021 Aug 16, 2021	SELL	$11.45 - $13.96 $273,403 - $333,336	-23,878 Reduced 12.54%	166,576 $2.23 Million
Q1 2021 May 17, 2021	BUY	$11.06 - $12.87 $524,044 - $609,806	47,382 Added 33.12%	190,454 $2.28 Million
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $129,071 - $172,648	13,834 Added 10.7%	143,072 $1.77 Million
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $98,362 - $137,973	9,522 Added 7.95%	129,238 $1.35 Million
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $662,375 - $879,708	57,648 Added 92.88%	119,716 $1.67 Million
Q1 2020 May 14, 2020	BUY	$8.11 - $15.23 $26,681 - $50,106	3,290 Added 5.6%	62,068 $730,000
Q4 2019 Feb 18, 2020	BUY	$10.28 - $14.38 $31,251 - $43,715	3,040 Added 5.45%	58,778 $832,000
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $75,576 - $109,416	7,520 Added 15.6%	55,738 $587,000
Q2 2019 Jul 31, 2019	SELL	$13.1 - $14.95 $25,531 - $29,137	-1,949 Reduced 3.89%	48,218 $702,000
Q1 2019 Apr 30, 2019	BUY	$13.69 - $20.06 $686,786 - $1.01 Million	50,167 New	50,167 $704,000

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Innoviva, Inc. Transaction History